Know Cancer

or
forgot password
  • cancer clinical trials in loma linda, CA

  • Efficacy and Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer
    Loma Linda University Dept.ofLomaLindaCancerCent(3)
    Loma Linda, California
    Metastatic Breast Cancer
    Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
    Veterans Affairs Medical Center - Loma Linda (Pettis)
    Loma Linda, California 92357
    Lung Cancer
    Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma
    Loma Linda University Cancer Institute at Loma Linda University Medical Center
    Loma Linda, California 92354
    Neuroblastoma
    Combination Chemotherapy With or Without Lestaurtinib in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
    Loma Linda University Cancer Institute at Loma Linda University Medical Center
    Loma Linda, California 92354
    Leukemia
    Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
    Loma Linda University Cancer Institute at Loma Linda University Medical Center
    Loma Linda, California 92354
    Neuroblastoma
    Proton Therapy for Early Stage Breast Cancer
    Loma Linda University Medical Center / James M. Slater MD Proton Treatment Center / Department of Radiation Medicine / 11234 Anderson St.
    Loma Linda, California 92354
    Early-Stage Breast Cancer
    Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
    Loma Linda University Medical Center
    Loma Linda, California 92354
    Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Angioimmunoblastic T-cell Lymphoma, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Grade III Lymphomatoid Granulomatosis, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, Essential Thrombocythemia, Extramedullary Plasmacytoma, Intraocular Lymphoma, Isolated Plasmacytoma of Bone, Juvenile Myelomonocytic Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Mast Cell Leukemia, Meningeal Chronic Myelogenous Leukemia, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Polycythemia Vera, Post-transplant Lymphoproliferative Disorder, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Primary Myelofibrosis, Primary Systemic Amyloidosis, Progressive Hairy Cell Leukemia, Initial Treatment, Prolymphocytic Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Stage 0 Chronic Lymphocytic Leukemia, Stage I Childhood Anaplastic Large Cell Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage I Childhood Large Cell Lymphoma, Stage I Childhood Lymphoblastic Lymphoma, Stage I Childhood Small Noncleaved Cell Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage II Childhood Anaplastic Large Cell Lymphoma, Stage II Childhood Hodgkin Lymphoma, Stage II Childhood Large Cell Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage II Childhood Small Noncleaved Cell Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Childhood Anaplastic Large Cell Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage III Childhood Small Noncleaved Cell Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage IV Childhood Anaplastic Large Cell Lymphoma, Stage IV Childhood Hodgkin Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, Stage IV Childhood Small Noncleaved Cell Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, T-cell Large Granular Lymphocyte Leukemia, Unspecified Childhood Solid Tumor, Protocol Specific, Untreated Childhood Acute Lymphoblastic Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies, Untreated Hairy Cell Leukemia, Waldenström Macroglobulinemia
    Doxorubicin Hydrochloride Liposome, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
    Loma Linda University Cancer Institute at Loma Linda University Medical Center
    Loma Linda, California 92354
    Multiple Myeloma and Plasma Cell Neoplasm
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Loma Linda University Medical Center
    Loma Linda, California 92354
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Salvage Cryotherapy in Recurrent Prostate Cancer
    Loma Linda University
    Loma Linda, California 92354
    Recurrent Prostate Cancer
    Study of Hypofractionated Proton Beam Radiation Therapy for Prostate Cancer
    Loma Linda University Medical Center / James M. Slater Proton Treatment Center
    Loma Linda, California 92354
    Prostate Cancer
    S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
    Loma Linda University Cancer Institute at Loma Linda University Medical Center
    Loma Linda, California 92354
    Breast Cancer
    Transarterial Chemoembolization Versus Proton Beam Radiotherapy for the Treatment of Hepatocellular Carcinoma
    Loma Linda University Medical Center
    Loma Linda, California 92354
    Carcinoma, Hepatocellular
    Study of Immunotherapy to Treat Advanced Prostate Cancer
    Loma Linda University Cancer Center
    Loma Linda, California 92354
    Prostate Cancer
    A Trial of ABI-007 Versus Dacarbazine in Previously Untreated Patients With Metastatic Malignant Melanoma
    Loma Linda University Cancer Center
    Loma Linda, California 92354
    Malignant Melanoma
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia
    Loma Linda University Cancer Institute at Loma Linda University Medical Center
    Loma Linda, California 92354
    Leukemia
    Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
    Loma Linda University Cancer Institute at Loma Linda University Medical Center
    Loma Linda, California 92354
    Leukemia, Lymphoma
    Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
    Loma Linda University Cancer Institute at Loma Linda University Medical Center
    Loma Linda, California 92354
    Leukemia, Lymphoma
    Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
    Loma Linda University Cancer Institute at Loma Linda University Medical Center
    Loma Linda, California 92354
    Leukemia, Neoplasm of Uncertain Malignant Potential, Unspecified Childhood Solid Tumor, Protocol Specific
    Study of Kidney Tumors in Young Patients
    Loma Linda University Cancer Institute at Loma Linda University Medical Center
    Loma Linda, California 92354
    Kidney Cancer, Nonneoplastic Condition
    Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma
    Loma Linda University Cancer Institute at Loma Linda University Medical Center
    Loma Linda, California 92354
    Sarcoma
    Collecting and Storing Biological Samples From Patients With Ewing Sarcoma
    Loma Linda University Cancer Institute at Loma Linda University Medical Center
    Loma Linda, California 92354
    Sarcoma
    Collecting and Storing Biological Samples From Young Patients With Hodgkin's Lymphoma
    Loma Linda University Cancer Institute at Loma Linda University Medical Center
    Loma Linda, California 92354
    Lymphoma
    Azacitidine and Cisplatin in Patients With Advanced Lung or Head and Neck Cancer
    Loma Linda University Cancer Center
    Loma Linda, California 92354
    Non-small Cell Lung Cancer, Squamous Cell Carcinoma of the Head and Neck
    Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
    Loma Linda University Cancer Institute at Loma Linda University Medical Center
    Loma Linda, California 92354
    Neuroblastoma
    Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma
    Loma Linda University Medical Center
    Loma Linda, California 92354
    Adult Rhabdomyosarcoma, Childhood Desmoplastic Small Round Cell Tumor, Chordoma, Desmoid Tumor, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors
    Loma Linda University Cancer Institute at Loma Linda University Medical Center
    Loma Linda, California 92354
    Brain and Central Nervous System Tumors
    Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients
    Loma Linda University Cancer Center
    Loma Linda, California 92354
    Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL)
    Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor
    Loma Linda University Medical Center
    Loma Linda, California 92354
    Diffuse Hyperplastic Perilobar Nephroblastomatosis, Rhabdoid Tumor of the Kidney, Stage I Wilms Tumor, Stage II Wilms Tumor, Stage III Wilms Tumor, Stage IV Wilms Tumor, Stage V Wilms Tumor
    Study of Blood Samples From Newborns With Down Syndrome
    Loma Linda University Cancer Institute at Loma Linda University Medical Center
    Loma Linda, California 92354
    Leukemia
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Liver Cancer
    Loma Linda University Medical Center
    Loma Linda, California 92354
    Childhood Hepatoblastoma, Stage I Childhood Liver Cancer, Stage II Childhood Liver Cancer, Stage III Childhood Liver Cancer, Stage IV Childhood Liver Cancer
    Care Partners: Web-based Support for Caregivers of Veterans Undergoing Chemotherapy
    VA Loma Linda Healthcare System, Loma Linda, CA
    Loma Linda, California 92357
    Cancer
    Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
    Loma Linda University Medical Center
    Loma Linda, California 92354
    Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage IV Childhood Hodgkin Lymphoma
    Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma
    Loma Linda University Medical Center
    Loma Linda, California 92354
    Disseminated Neuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma, Stage 4S Neuroblastoma
    Determining the Lymphokine Activated Killer (LAK) Cytotoxicity Present in Patients Undergoing Interleukin-2 Therapy
    Loma Linda University Cancer Center
    Loma Linda, California 92354
    Melanoma, Kidney Cancer
    Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma
    Loma Linda University Medical Center
    Loma Linda, California 92354
    Adenocarcinoma of the Extrahepatic Bile Duct, Adenocarcinoma of the Gallbladder, Adenocarcinoma With Squamous Metaplasia of the Gallbladder, Anaplastic Carcinoma of the Gallbladder, Cholangiocarcinoma of the Extrahepatic Bile Duct, Cholangiocarcinoma of the Gallbladder, Recurrent Extrahepatic Bile Duct Cancer, Recurrent Gallbladder Cancer, Unresectable Extrahepatic Bile Duct Cancer, Unresectable Gallbladder Cancer
    Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients With Newly Diagnosed Ependymoma
    Loma Linda University Medical Center
    Loma Linda, California 92354
    Childhood Infratentorial Ependymoma, Childhood Supratentorial Ependymoma, Newly Diagnosed Childhood Ependymoma
    Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma
    Loma Linda University Medical Center
    Loma Linda, California 92354
    Acral Lentiginous Malignant Melanoma, Lentigo Maligna Malignant Melanoma, Nodular Malignant Melanoma, Recurrent Melanoma, Solar Radiation-related Skin Melanoma, Stage IV Melanoma, Superficial Spreading Malignant Melanoma
    Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment
    Investigational Site Number 840013
    Loma Linda, California 92354
    Neoplasm Malignant
    Proton Beam Radiotherapy Plus Sorafenib Versus Sorafenib for Patients With Hepatocellular Carcinoma Exceeding San Francisco Criteria
    Loma Linda University Medical Center
    Loma Linda, California 92354
    Carcinoma, Hepatocellular
    Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Loma Linda University Cancer Institute at Loma Linda University Medical Center
    Loma Linda, California 92354
    Leukemia
    A Multicenter, Open-label Study of CMX001 Treatment of Serious Diseases or Conditions Caused by dsDNA Viruses
    Loma Linda University Hospital
    Loma Linda, California 92354
    Male or Female Patients With a Serious or Immediately Life-threatening, Disease or Condition Caused by CMV, ADV, HSV, VAVC, VARV or, Monkeypox Viruses(s) Who Have a Life Expectancy of ≥ 2 Weeks and for, Whom no Comparable or Satisfactory Alternative Therapy is Available
    A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positive Non Squamous Cancer Of The Lung
    Loma Linda University Medical Center

    Trial Locations
    Loma Linda University Medical Center
    Loma Linda University Medical Center Pharmacy
    Loma Linda University Cancer Center-Schuman Pavilion
    Records Management Only- Loma Linda Cancer Center
    Non Squamous Lung Cancer
    Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors
    Loma Linda University Medical Center
    Loma Linda, California 92354
    Recurrent Childhood Medulloblastoma, Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor
    Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma
    Loma Linda University Medical Center
    Loma Linda, California 92354
    Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Mixed Childhood Rhabdomyosarcoma, Pleomorphic Childhood Rhabdomyosarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma
    Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma
    Loma Linda University Medical Center
    Loma Linda, California 92354
    Adult Supratentorial Primitive Neuroectodermal Tumor (PNET), Childhood Supratentorial Primitive Neuroectodermal Tumor, Ewing Sarcoma of Bone, Extraosseous Ewing Sarcoma, Extraosseous Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Peripheral Primitive Neuroectodermal Tumor of the Kidney, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma
    Loma Linda University Medical Center
    Loma Linda, California 92354
    Childhood High-grade Cerebellar Astrocytoma, Childhood High-grade Cerebral Astrocytoma, Childhood Spinal Cord Neoplasm, Untreated Childhood Brain Stem Glioma, Untreated Childhood Cerebral Astrocytoma
    Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance
    Loma Linda University Cancer Institute at Loma Linda University Medical Center
    Loma Linda, California 92354
    Prostate Cancer
    Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM)
    VA Loma Linda Healthcare System, Loma Linda, CA
    Loma Linda, California 92357
    Colorectal Cancer
    A Study of DS-2248, in Subjects With Advanced Solid Tumors
    Loma Linda University Medical Center
    Loma Linda, California 92354
    Solid Tumors, Non-small Cell Lung Carcinoma
    Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy
    Loma Linda University Cancer Institute at Loma Linda University Medical Center
    Loma Linda, California 92354
    Fungal Infection, Leukemia, Neutropenia
    Partial Breast Proton Therapy for Early Stage Breast Cancer
    Loma Linda University Medical Center

    Trial Locations
    Loma Linda University Medical Center
    Loma Linda University Medical Center / James M. Slater MD Proton Treatment Center / Department of Radiation Medicine / 11234 Anderson St.
    Breast Cancer, Early Stage
    Levofloxacin in Preventing Infection in Young Patients Receiving Chemotherapy For Acute Leukemia or Undergoing Stem Cell Transplantation
    Loma Linda University Cancer Institute at Loma Linda University Medical Center
    Loma Linda, California 92354
    Bacterial Infection, Leukemia, Musculoskeletal Complications, Neutropenia
    Bortezomib and Sorafenib Tosylate in Patients With Newly Diagnosed Acute Myeloid Leukemia With or Without Mutations
    Loma Linda University Medical Center
    Loma Linda, California 92354
    Adult Acute Erythroid Leukemia (M6), Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Pure Erythroid Leukemia (M6b), Childhood Acute Erythroleukemia (M6), Childhood Acute Megakaryocytic Leukemia (M7), Childhood Acute Minimally Differentiated Myeloid Leukemia (M0), Childhood Acute Monoblastic Leukemia (M5a), Childhood Acute Monocytic Leukemia (M5b), Childhood Acute Myeloblastic Leukemia With Maturation (M2), Childhood Acute Myeloblastic Leukemia Without Maturation (M1), Childhood Acute Myelomonocytic Leukemia (M4), Untreated Adult Acute Myeloid Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
    Loma Linda University Medical Center
    Loma Linda, California 92354
    B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia, Cognitive/Functional Effects, Neurotoxicity, Pain, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Therapy-related Toxicity, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    S1013: Validation of Cancer Questionnaire for Skin Toxicities in Patients With Colorectal Cancer or Lung Cancer Receiving Cetuximab, Panitumumab, or Erlotinib Hydrochloride
    Loma Linda University Cancer Institute at Loma Linda University Medical Center
    Loma Linda, California 92354
    Colorectal Cancer, Dermatologic Complications, Lung Cancer, Therapy-related Toxicity
    Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
    Antranik Agop Bedros
    Loma Linda, California 92350
    Leukemia, Pediatric
    Chemotherapy Plus Proton-chemotherapy for Locally Advanced Pancreatic Cancer
    Loma Linda University Medical Center
    Loma Linda, California 92354
    Pancreatic Cancer
    Proton Therapy for Esophageal Cancer
    Loma Linda University Medical Center
    Loma Linda, California 92354
    Esophageal Cancer
    Proton Therapy in the Treatment of Liver Metastases
    Loma Linda University Medical Center
    Loma Linda, California 92354
    Liver Metastases